-
公开(公告)号：US08193206B2
公开(公告)日：2012-06-05
申请号：US12330132
申请日：2008-12-08
Applicant: Chi-Feng Yen , Cheng-Kung Hu , Ming-Chen Chou , Chen-Tso Tseng , Chien-Huang Wu , Ying-Huey Huang , Shu-Jen Chen , Chi-Hsin Richard King
Inventor： Chi-Feng Yen , Cheng-Kung Hu , Ming-Chen Chou , Chen-Tso Tseng , Chien-Huang Wu , Ying-Huey Huang , Shu-Jen Chen , Chi-Hsin Richard King
IPC: A61K31/505 , A61K31/506
CPC classification number: A61K31/506 , A61K31/5377 , A61K31/55 , A61K38/193 , A61K2300/00
Abstract: This invention relates to a method for treating inflammatory diseases or immune diseases, developmental or degenerative diseases, or tissue injuries. The method includes administering to a subject in need thereof an effective amount of one or more compounds of formula (I). Each variable in this formula is defined in the specification.
Abstract translation: 本发明涉及一种治疗炎性疾病或免疫疾病，发育或退行性疾病或组织损伤的方法。 该方法包括向有需要的受试者施用有效量的一种或多种式（I）化合物。 该公式中的每个变量在规范中定义。
-
公开(公告)号：US07589197B2
公开(公告)日：2009-09-15
申请号：US11451771
申请日：2006-06-13
Applicant: Chi-Feng Yen , Cheng-Kung Hu , Ming-Chen Chou , Chen-Tso Tseng , Chien-Huang Wu , Ying-Huey Huang , Shu-Jen Chen , Chi-Hsin Richard King
Inventor： Chi-Feng Yen , Cheng-Kung Hu , Ming-Chen Chou , Chen-Tso Tseng , Chien-Huang Wu , Ying-Huey Huang , Shu-Jen Chen , Chi-Hsin Richard King
IPC: C07D265/30 , C07D413/14 , C07D403/14
CPC classification number: C07D239/48 , A61K31/506 , A61K31/5377 , A61K31/55 , A61K38/193 , C07D239/42 , C07D239/50 , C07D401/04 , C07D401/12 , C07D401/14 , C07D403/04 , C07D403/12 , C07D403/14 , C07D405/12 , C07D409/12 , A61K2300/00
Abstract: This invention relates to a method for treating inflammatory diseases or immune diseases, developmental or degenerative diseases, or tissue injuries. The method includes administering to a subject in need thereof an effective amount of one or more compounds of formula (I). Each variable in this formula is defined in the specification.
Abstract translation: 本发明涉及一种治疗炎性疾病或免疫疾病，发育或退行性疾病或组织损伤的方法。 该方法包括向有需要的受试者施用有效量的一种或多种式（I）化合物。 该公式中的每个变量在规范中定义。
-
公开(公告)号：US20090214529A9
公开(公告)日：2009-08-27
申请号：US12125094
申请日：2008-05-22
Applicant: Ching-Cheng Wang , Hung-Chuan Chen , Shu-Huei Wang , Mei-Chun Lin , Tien-Lan Shieh , Ying-Huey Huang , Shih-Chieh Chuang , Chi-Hsin Richard King
Inventor： Ching-Cheng Wang , Hung-Chuan Chen , Shu-Huei Wang , Mei-Chun Lin , Tien-Lan Shieh , Ying-Huey Huang , Shih-Chieh Chuang , Chi-Hsin Richard King
IPC: A61K33/24 , C07D239/70 , C07D253/10 , A61K31/495 , A61K31/53 , A61K31/439 , A61K31/4375 , A61K31/728 , A61K31/675 , A61K31/337 , A61K31/506 , A61K39/395 , A61K31/505 , A61K31/519 , A61K31/282 , A61P35/00 , A61P37/02
CPC classification number: A61K31/282 , A61K31/337 , A61K31/4375 , A61K31/439 , A61K31/495 , A61K31/505 , A61K31/506 , A61K31/519 , A61K31/53 , A61K31/555 , A61K31/675 , A61K31/728 , A61K33/24 , A61K45/06 , C07D239/70 , C07D253/10 , C07D409/06 , C07D471/04 , C07D487/04 , C07D491/04 , C07D495/04 , C07D495/14 , C07D498/04 , A61K2300/00
Abstract: This invention relates to the compounds of formula (I) shown below. Each variable in formula (I) is defined in the specification. These compounds can be used to treat a kinesin Eg5 protein-mediated disorder.
Abstract translation: 本发明涉及下面所示的式（I）化合物。 式（I）中的每个变量在说明书中定义。 这些化合物可用于治疗运动蛋白Eg5蛋白介导的病症。
-
公开(公告)号：US07504422B2
公开(公告)日：2009-03-17
申请号：US11834204
申请日：2007-08-06
Applicant: Chi-Feng Yen , Chi-Hsin Richard King , Hua-Chien Chen , Gholam Hossein Hakimelahi , Shu-Jen Chen , Ying-Huey Huang , Chien-Huang Wu
Inventor： Chi-Feng Yen , Chi-Hsin Richard King , Hua-Chien Chen , Gholam Hossein Hakimelahi , Shu-Jen Chen , Ying-Huey Huang , Chien-Huang Wu
IPC: A61K31/44 , A61K31/40 , A61K31/18 , A61K31/165 , A61K31/15 , A61K31/135
CPC classification number: C07D207/335 , A61K31/135 , A61K31/15 , A61K31/165 , A61K31/195 , A61K31/44 , A61K31/445 , C07C211/27 , C07C211/29 , C07C211/30 , C07D209/08 , C07D213/38 , C07D213/42 , C07D213/74 , C07D235/14 , C07D257/02 , C07D333/18 , C07D401/14 , C07D409/14 , C07D471/04
Abstract: This invention relates to methods for treating retinopathy and repairing tissue damage. The methods include administering to a subject in need thereof an effective amount of one or more compounds of the following formula. Each variable in this formula is defined in the specification.
Abstract translation: 本发明涉及治疗视网膜病变和修复组织损伤的方法。 所述方法包括向有需要的受试者施用有效量的一种或多种下列化合物。 该公式中的每个变量在规范中定义。
-
公开(公告)号：US20090264339A1
公开(公告)日：2009-10-22
申请号：US12263671
申请日：2008-11-03
Applicant: Chi-Feng Yen , Cheng-Kung Hu , Chang-Pin Huang , Ying-Huey Huang , Gholam Hossein Hakimelahi , Chi-Hsin Richard King
Inventor： Chi-Feng Yen , Cheng-Kung Hu , Chang-Pin Huang , Ying-Huey Huang , Gholam Hossein Hakimelahi , Chi-Hsin Richard King
IPC: A61K38/14 , C07D403/02 , A61K31/496 , C07F9/28 , A61P29/00 , A61P27/02 , A61P9/00 , A61P13/12 , A61P3/10 , A61P11/00 , A61P17/00 , A61P25/00 , A61P37/00 , A61K31/675 , A61K31/53 , C07D251/12
CPC classification number: C07D239/50 , C07D251/54 , C07D403/04
Abstract: This invention relates to heterocyclic compounds of the formulas shown in the specification. It also relates to methods for treating inflammatory diseases or immune diseases, developmental or degenerative diseases, and tissue injuries with one of the heterocyclic compounds.
Abstract translation: 本发明涉及说明书中所示的式的杂环化合物。 它还涉及用一种杂环化合物治疗炎症性疾病或免疫疾病，发育性或退行性疾病以及组织损伤的方法。
-
Patent Agency Ranking
公开(公告)号：US20090143302A1
公开(公告)日：2009-06-04
申请号：US12330132
申请日：2008-12-08
Applicant: Chi-Feng Yen , Cheng-Kung Hu , Ming-Chen Chou , Chen-Tso Tseng , Chien-Huang Wu , Ying-Huey Huang , Shu-Jen Chen , Chi-Hsin Richard King
Inventor： Chi-Feng Yen , Cheng-Kung Hu , Ming-Chen Chou , Chen-Tso Tseng , Chien-Huang Wu , Ying-Huey Huang , Shu-Jen Chen , Chi-Hsin Richard King
IPC: A61K38/18 , A61K31/55 , A61K31/505 , A61P7/00 , A61K31/506
CPC classification number: A61K31/506 , A61K31/5377 , A61K31/55 , A61K38/193 , A61K2300/00
Abstract: This invention relates to a method for treating inflammatory diseases or immune diseases, developmental or degenerative diseases, or tissue injuries. The method includes administering to a subject in need thereof an effective amount of one or more compounds of formula (I). Each variable in this formula is defined in the specification.
Abstract translation: 本发明涉及一种治疗炎性疾病或免疫疾病，发育或退行性疾病或组织损伤的方法。 该方法包括向有需要的受试者施用有效量的一种或多种式（I）化合物。 该公式中的每个变量在规范中定义。
-
公开(公告)号：US20060293324A1
公开(公告)日：2006-12-28
申请号：US11451771
申请日：2006-06-13
Applicant: Chi-Feng Yen , Cheng-Kung Hu , Ming-Chen Chou , Chen-Tso Tseng , Chien-Huang Wu , Ying-Huey Huang , Shu-Jen Chen , Chi-Hsin King
Inventor： Chi-Feng Yen , Cheng-Kung Hu , Ming-Chen Chou , Chen-Tso Tseng , Chien-Huang Wu , Ying-Huey Huang , Shu-Jen Chen , Chi-Hsin King
IPC: A61K31/5377 , A61K31/506 , C07D413/14 , C07D403/02
CPC classification number: C07D239/48 , A61K31/506 , A61K31/5377 , A61K31/55 , A61K38/193 , C07D239/42 , C07D239/50 , C07D401/04 , C07D401/12 , C07D401/14 , C07D403/04 , C07D403/12 , C07D403/14 , C07D405/12 , C07D409/12 , A61K2300/00
Abstract: This invention relates to a method for treating inflammatory diseases or immune diseases, developmental or degenerative diseases, or tissue injuries. The method includes administering to a subject in need thereof an effective amount of one or more compounds of formula (I). Each variable in this formula is defined in the specification.
-
公开(公告)号：US20060281712A1
公开(公告)日：2006-12-14
申请号：US11451897
申请日：2006-06-13
Applicant: Chi-Feng Yen , Cheng-Kung Hu , Ming-Chen Chou , Chen-Tso Tseng , Chien-Huang Wu , Ying-Huey Huang , Shu-Jen Chen , Chi-Hsin King
Inventor： Chi-Feng Yen , Cheng-Kung Hu , Ming-Chen Chou , Chen-Tso Tseng , Chien-Huang Wu , Ying-Huey Huang , Shu-Jen Chen , Chi-Hsin King
IPC: A61K38/19 , A61K31/55 , A61K31/5377 , A61K31/506 , A61K31/675
CPC classification number: C07D239/48 , A61K31/506 , A61K31/5377 , A61K31/55 , A61K38/193 , C07D239/42 , C07D239/50 , C07D401/04 , C07D401/12 , C07D401/14 , C07D403/04 , C07D403/12 , C07D403/14 , C07D405/12 , C07D409/12 , A61K2300/00
Abstract: This invention relates to a method for treating inflammatory diseases or immune diseases, developmental or degenerative diseases, or tissue injuries. The method includes administering to a subject in need thereof an effective amount of one or more compounds of formula (I). Each variable in this formula is defined in the specification.
-
公开(公告)号：US20060036093A1
公开(公告)日：2006-02-16
申请号：US11204792
申请日：2005-08-16
Applicant: Chu-Chung Lin , Hong-Chuan Chen , Kuang-Yuan Lee , Ying-Huey Huang , Yang-Ping Fan , Yibin Xiang
Inventor： Chu-Chung Lin , Hong-Chuan Chen , Kuang-Yuan Lee , Ying-Huey Huang , Yang-Ping Fan , Yibin Xiang
IPC: A61K31/519 , C07D239/72 , C07D487/02
CPC classification number: C07D471/04 , C07D239/90 , C07D239/95 , C07D401/12 , C07D403/12 , C07D409/12 , C07D417/14 , C07D495/04
Abstract: This invention relates to treating inflammatory and immune diseases with certain pyrimidinone compounds that bind to CXCR3 receptors. The pyrimidinone compounds are covered by the formula (I) shown below. Each variable is defined in the specification.
Abstract translation: 本发明涉及用与CXCR3受体结合的某些嘧啶酮化合物治疗炎症和免疫疾病。 嘧啶酮化合物被下面所示的式（I）覆盖。 每个变量在规范中定义。
-
10.发明申请公开(公告)号：US20050043366A1
公开(公告)日：2005-02-24
申请号：US10814058
申请日：2004-03-30
Applicant: Kak-Shan Shia , Gholam Hakimelahi , Jia-Liang Zhu , Chi-Feng Yen , Ying-Huey Huang , Yibin Xiang , Hua-Chien Chen , Ching-Cheng Wang
Inventor： Kak-Shan Shia , Gholam Hakimelahi , Jia-Liang Zhu , Chi-Feng Yen , Ying-Huey Huang , Yibin Xiang , Hua-Chien Chen , Ching-Cheng Wang
IPC: A61K31/135 , A61K31/15 , A61K31/165 , A61K31/195 , A61K31/44 , A61K31/445 , C07C211/27 , C07C211/29 , C07C211/30 , C07D207/32 , C07D207/335 , C07D209/08 , C07D213/38 , C07D213/42 , C07D213/74 , C07D235/10 , C07D235/14 , C07D257/02 , C07D333/18 , C07D401/14 , C07D409/14 , C07D471/04
CPC classification number: C07D207/335 , A61K31/135 , A61K31/15 , A61K31/165 , A61K31/195 , A61K31/44 , A61K31/445 , C07C211/27 , C07C211/29 , C07C211/30 , C07D209/08 , C07D213/38 , C07D213/42 , C07D213/74 , C07D235/14 , C07D257/02 , C07D333/18 , C07D401/14 , C07D409/14 , C07D471/04
Abstract: This invention relates to a method for treating inflammatory diseases or immune diseases, developmental or degenerative diseases, or tissue injuries. The method includes administering to a subject in need thereof an effective amount of one or more compounds of the following formula. Each variable in this formula is defined in the specification.
Abstract translation: 本发明涉及一种治疗炎性疾病或免疫疾病，发育或退行性疾病或组织损伤的方法。 该方法包括向有需要的受试者施用有效量的一种或多种下列化合物。 该公式中的每个变量在规范中定义。
-
-
-
-
-
-
-
-
-
Search Results
15
records
(took 0.026 seconds)
